References
- Young SN. Bias in the research literature and conflict of interest: an issue for publishers, editors, reviewers and authors, and it is not just about money. J Psychiatry Neurosci 2009;34: 412–7
- World Association of Medical Editors. Conflicts of interest in peer-reviewed medical journals. J Child Neurol 2009;24: 1321–3
- Dorsey ER, de Roulet J, Thompson JP, et al. Funding of US Biomedical Research, 2003–2008. JAMA 2010;303:137–43
- Roth JA, Etzioni R, Waters TM, et al. Economic return from the Women's Health Initiative estrogen plus progestin clinical trial. Ann Intern Med 2014;160:594–602
- Pickar JH. Do journals have a publication bias? Maturitas 2007; 57:16–9
- Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419–27
- Whitehead M, Farmer R. The Million Women Study: a critique. Endocrine 2004;24:187–93
- Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study (Department of Error). Lancet 2003;362:1160
- Fontanarosa PB, DeAngelis CD. The importance of the journal embargo. JAMA 2002;288:748–50
- Karim R, Dell RM, Greene DF, et al. Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization. Menopause 2011;18:1172–7
- Sarrel PM, Njike VY, Vinante V, Katz DL. The mortality toll of estrogen avoidance: an analysis of excess deaths among hysterectomized women aged 50 to 59 years. Am J Public Health 2013;103:1583–8
- About this journal. JAMA 2003;290:296
- About this journal. JAMA 2003;290:2096
- About this journal. JAMA 2004;292:2692
- Resnik DB, Elliott KC. Taking financial relationships into account when assessing research. Account Res 2013;20: 184–205
- Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. principal results from the Women's Health Initiative randomized clinical trial. JAMA 2002;288: 321–33
- Freedman L, Anderson G, Kipnis V, et al. Guidelines for the statistical monitoring of the Women's Health Initiative Clinical Trial; 1 April 1998
- NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk, lack of overall benefit. National Institutes of Health, NIH News Release; 9 July 2002
- Stevenson JC, Hodis, HN, Pickar JH, Lobo RA. Coronary heart disease and menopause management: The swinging pendulum of HRT. Atherosclerosis 2009;207:336–40
- Utian WH. A decade post WHI, menopausal hormone therapy comes full circle – need for independent commission. Climacteric 2012;15:320–5
- White AP, Vaccaro AR, Zdeblick T. Physician-industry relationships can be ethically established, and conflicts of interest can be ethically managed. Spine 2007;32(11 Suppl):S53–7
- Levinsky NG. Nonfinancial conflicts of interest in research. NEJM 2002;347:759–61
- Agrawal S, Brennan N, Budetti P. The Sunshine Act – effects on physicians. NEJM 2013;368:2054–7
- Lach HW. Financial conflicts of interest in research. Recognition and management. Nurs Res 2014;63:228–32
- Fisher CG, DiPaola CP, Noonan VK, Bailey C, Dvorak MFS. Physician-industry conflict of interest: public opinion regarding industry sponsored research. J Neurosurg: Spine 2012;17:1–10
- The Harris Poll. Doctors and teachers most trusted among 22 occupations and professions: fewer adults trust the President to tell the truth. Harris Interactive 2006 (http://www.b2i.us/profiles/investor/NewsPDF.asp?b = 1963&ID = 34138&m = rl) Accessed December 2014